SavedAdd your journal

Journals / Journal of Contemporary Medicine / 2023 / Cilt: 13 - Sayı: 1

Immunohistochemical Expression of B Cell Transcription Factors in Hodgkin’s Lymphoma and Their Use in Differential Diagnosis

Hodgkin Lenfomada B Hücre Transkripsiyon Faktörlerinin İmmünohistokimyasal İfadesi ve Ayırıcı Tanıda Kullanımı

Çiğdem ÖZDEMİR
Filiz YAVAŞOĞLU
Yiğit ŞENOL
Pages
92–99
Publication Date
2023-01-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a statistically significant difference in CD30, OCT-2, BOB.1, MUM-1, PAX-5, CD20, BCL-6, EBER expression between CHL and DLBCL cases (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Classical Hodgkin lymphoma is common, it is one of the lymphomas whose differential diagnosis can be difficult.
📊
Key Findings & Data:Our aim in this study was to determine the germinal center transformation markers OCT-2, BOB.1, BCL-6, PAX-5, CD20 and MUM-1 in Classic Hodgkin Lymphoma (CHL), Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Diffuse Large B-cell Lymphoma (DLBCL) to evaluate the expressions of by immunohistochemical method and chromogenic in-situ hybridization (ISH) of EBV early RNAs (EBER).
💡
Conclusion & Impact:There was a statistically significant difference in CD30, OCT-2, BOB.1, MUM-1, PAX-5, CD20, BCL-6, EBER expression between CHL and DLBCL cases (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hodgkin’s Lymphoma · BOB.1 · OCT-2

Abstract

Aim: Classical Hodgkin lymphoma is common, it is one of the lymphomas whose differential diagnosis can be difficult. It is thought that Hodgkin cell may originate from the germinal center. Our aim in this study was to determine the germinal center transformation markers OCT-2, BOB.1, BCL-6, PAX-5, CD20 and MUM-1 in Classic Hodgkin Lymphoma (CHL), Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Diffuse Large B-cell Lymphoma (DLBCL) to evaluate the expressions of by immunohistochemical method and chromogenic in-situ hybridization (ISH) of EBV early RNAs (EBER). Material and methods: 49 biopsies diagnosed with Hodgkin lymphoma (HL), 5 with NLPHL and 19 with DLBCL were evaluated for CD30, PAX-5, OCT-2, BOB.1, MUM-1, BCL-6, and CD20, and EBER positivity. SPSS 18 was used for statistical analysis. Results: 73 lymphoma cases were included in the study, 61.6% males and 38.4% females. The median age of patients was 50 years. CHL (67.1%) was the most common lymphoma type, and mixed cellular Hodgkin lymphoma (MSHL) was the most common subtype. There was a statistically significant difference in CD30, OCT-2, BOB.1, MUM-1, PAX-5, CD20, BCL-6, EBER expression between CHL and DLBCL cases (p

Özet

ÖZ Amaç: Klasik Hodgkin Lenfoma sık görülmek ile birlikte ayrıcı tanısı zor olabilen lenfomalardandır. Hodgkin hücresinin germinal merkezli olabileceği düşünülmektedir. Bu çalışmadaki amacımız, Classic Hodgkin Lymphoma (CHL), Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) ve diffuse large B-cell lymphoma (DLBCL)’da germinal merkez transformasyon belirteçleri olan OCT-2, BOB.1, BCL-6, PAX-5, CD20 ve MUM-1’in ekspresyonlarını immünohistokimyasal yöntem ile, EBV early RNAs (EBER)’in chromogenic in-situ hybridization (ISH) ile değerlendirmektir. Gereç ve yöntemler: 49 Hodgkin lenfoma (HL), 5'i NLPHL ve 19'u DLBCL tanılı biyopsi CD30, PAX-5, OCT-2, BOB.1, MUM-1, BCL-6 ve CD20 ve EBER pozitifliği açısından değerlendirildi. İstatistiksel analiz için SPSS 18 kullanıldı. Bulgular: Çalışmaya %61.6 erkek ve %38.4 kadın olmak üzere 73 lenfoma olgusu dahil edildi. Hastaların medyan yaşı 50 idi. En sık görülen lenfoma tipi CHL (%67,1), en sık görülen alt tip mikst hücreli Hodgkin lenfoma (MSHL) idi. CHL ve DLBCL olguları arasında CD30, OCT-2, BOB.1, MUM-1, PAX-5, CD20, BCL-6, EBER ekspresyonu açısından istatistiksel olarak anlamlı fark vardı (p

🔖

Cite This Article

ÖZDEMİR, Ç., YAVAŞOĞLU, F., ŞENOL, Y. (2023). Immunohistochemical Expression of B Cell Transcription Factors in Hodgkin’s Lymphoma and Their Use in Differential Diagnosis. Journal of Contemporary Medicine, Cilt: 13 - Sayı: 1, 92–99. https://ajindex.com/articles/880726

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. de Leval L, Jaffe ES. Lymphoma classification. The Cancer Journal. 2020;26(3):176-85
  2. Swerdlow SH CE HN, Jaffe ES, Pileri SA, Stein H, Thit Rele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Sieber. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer 2017
  3. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-48
  4. McCune RC, Syrbu SI, Vasef MA. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB. 1, and PU. 1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays. Modern pathology. 2006;19(7):1010-8
  5. Khan MR, Ahmad A, Kayani N, Minhas K. Expression of PAX-5 in B cell hodgkin and non hodgkin lymphoma. Asian Pacific Journal of Cancer Prevention: APJCP. 2018;19(12):3463
  6. Torlakovic E, Tierens A, Dang HD, Delabie J. The transcription factor PU. 1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin’s disease. The American journal of pathology. 2001;159(5):1807-14
  7. Browne P, Petrosyan K, Hernandez A, Chan JA. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol. 2003;120(5):767-77
  8. O’Malley DP, Fedoriw Y, Weiss LM. Distinguishing classical Hodgkin lymphoma, gray zone lymphoma, and large B-cell lymphoma: a proposed scoring system. Applied Immunohistochemistry & Molecular Morphology. 2016;24(8):535-40
  9. Watanabe T, Kitazawa R, Mizuno Y, Kuwahara N, Ito C, Sugita A, et al. BOB. 1-positive classical Hodgkin’s Lymphoma carries hypermethylation of its promoter as epigenetic marker of gene-silencing memory. Acta Histochemica et Cytochemica. 2014;47(3):125-31
  10. O'Malley DP, Fedoriw Y, Weiss LM. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System. Appl Immunohistochem Mol Morphol. 2016;24(8):535-40
  11. García-Cosío M, Santón A, Martín P, Camarasa N, Montalbán C, García JF, et al. Analysis of transcription factor OCT. 1, OCT. 2 and BOB. 1 expression using tissue arrays in classical Hodgkin's lymphoma. Modern pathology. 2004;17(12):1531-8
  12. Şeker M, Mengi A, Bilici A, Ustaalioğlu BB, Kefeli U,